iCAD image analysis software program used in DCE-MRI studies demonstrated at ASCO 2010

ACR Image Metrix^TM, an imaging contract research organization (CRO) with expertise in imaging trial design, techniques and data extraction, in conjunction with its software partner, iCAD, gave demonstrations of the iCAD image analysis software program used in DCE-MRI studies at the ACR Image Metrix booth during the 2010 Annual American Society of Clinical Oncology (ASCO) Meeting, which took place June 4-8, 2010, in Chicago, IL.

“Partnering with iCAD allows us to offer our sponsors in the oncology drug research arena more advanced solutions to understanding their compounds in the early phase studies using novel imaging modalities such as DCE-MRI”

iCAD, a computer-aided detection (CAD) company and an industry leader in providing advanced imaging analysis and workflow solutions to healthcare professionals, partnered with ACR Image Metrix for advanced solutions in DCE-MRI clinical research studies for pharmaceutical and biotechnology companies.

"Partnering with iCAD allows us to offer our sponsors in the oncology drug research arena more advanced solutions to understanding their compounds in the early phase studies using novel imaging modalities such as DCE-MRI," said General Manager of ACR Image Metrix Michael J. Morales. "We found an extremely high level of interest at ASCO and we are pleased iCAD was able to be present at our booth to demonstrate this innovative software technology."

As one of the industry's leading imaging CROs, ACR Image Metrix specializes in providing imaging CRO services to assist pharmaceutical, biotech and medical device companies around the world.